Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial.
about
Therapeutic modification of arterial stiffness: An update and comprehensive reviewEthinylestradiol30μg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential.Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome.Arterial stiffness and cardiovascular therapyThe American Diabetes Association's 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea.Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes.Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study.Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial.Assessing and treating insulin resistance in women with polycystic ovarian syndromeThe effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.Longterm management of Polycystic Ovarian Syndrome (PCOS)Implications for reproductive medicine: Sex differences in cardiovascular diseasePrognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat.Arterial compliance is increased in children with type 2 diabetes compared with normal weight peers but not obese peers.Cardiovascular Risk in Women With PCOS.Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study.Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null miceThe effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.Association between circulating adiponectin levels and polycystic ovarian syndrome.Pharmacological modulation of arterial stiffness.Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics.The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.Metformin therapy in diabetes: the role of cardioprotection.Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease.Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions.Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension?Central Hemodynamics for Management of Arteriosclerotic Diseases.Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients.Relationship Between Serum Total Testosterone Concentration and Augmentation Index at Radial Artery in Japanese Postmenopausal Patients.Effect of Metformin-sustained Release Therapy on Low-density Lipoprotein Size and Adiponectin in the South Indian Women with Polycystic Ovary Syndrome.Metformin improves endothelial function and carotid intima media thickness in patients with PCOS.The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
P2860
Q26774555-BD214472-76F0-4DCD-9DAF-2DC1AAD646F3Q31065780-9591D649-640D-4544-8BE2-37001ADB1603Q33656442-116D0A06-87EF-4DCE-8806-B22639DA1099Q33927310-C1E1FE9A-404A-4352-B909-C51C1DB2A1E4Q34079790-669F607F-98FA-4BDB-954A-7B18E766D4E0Q34421903-17DA5341-347F-442C-A2B8-2AAEE1ADA704Q34594675-E3FDA79D-B973-4514-9688-BCE9C9F1BE88Q34762025-207C3A83-9B75-4D96-801D-CAF6389161DFQ34766224-A9B158E4-B62E-40ED-9500-443F84CCCA2DQ34817037-1D99FA33-B65F-4874-BA1D-51266FFEB948Q34833061-61BBD1F6-DDF6-46E5-8603-62D1D055C19CQ34878055-D5567B94-AF17-46AD-9764-D71916760BC7Q35181929-DE0E6CD6-7C1A-46B9-8909-CEDFD4E63084Q35200094-1C240F50-5EE4-4E6B-B437-AAAC992C0238Q35205039-BC563A2C-27C1-4E0D-9DD0-0D76503C80F4Q35665099-C0513089-63C4-405E-B634-C4E3A84A7ECFQ36316335-D4227373-61C8-45B8-BBAC-69F61EABE60DQ36764442-C5D31CCD-C66D-4340-8E8B-D2952A445340Q36881500-8B8DD817-A1C3-4D29-BEBF-7134CBE979B9Q36957415-DB3DC51D-A312-44D8-9F3F-A471DEE02726Q37042240-92BF107E-2C7E-433F-BE44-DBC50594606AQ37550688-3CACEE1A-A8AB-4E29-A039-D1F7A070BF41Q37559421-81026427-1BFB-46A6-B331-1959377649EBQ37591691-58D3E4BB-D2A4-4384-9D01-AB8372FBC50DQ37929160-C0FCA4B2-F4CA-4F17-953C-EC81B2007C10Q37990356-8A750A1F-EDB8-461A-B0AE-3AF8BD5250F7Q38006018-B03442ED-FF7D-4D48-B186-4308C8F6CE9BQ38075845-8D03EE11-4919-4D43-9D3C-3CCC0959F356Q38083008-358DA9B6-948F-4D25-ADE7-52BE2834C2BAQ38102595-7D2D1582-803A-401C-8610-8EC78A8A144EQ38374396-A0F670B8-A8A4-48AE-A127-6E7420B4D297Q38587721-079DDA75-497C-42D4-8907-3193A4E12D05Q39036760-F39ACA8A-D346-4F4C-AB8E-48867B569B66Q39158946-4F7BF2CD-1A8A-45F1-A1F3-AC4FB4A114CAQ39365627-D49DD64D-217A-4464-A9A2-859250789984Q41343028-33F80D60-C8F4-4A18-BA95-F453414F6D43Q41353598-CD149FE2-9130-4C26-BF80-0AA57709398BQ41993621-2C1AD86C-72D8-4987-B10C-747F8A5A066AQ42474494-C5985EB5-44F7-43AB-96C6-6A2C92A533E1Q42505925-FF826DD6-8800-43DB-A1C0-2661F5FF4992
P2860
Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Metformin reduces arterial sti ...... o-controlled, crossover trial.
@en
Metformin reduces arterial sti ...... o-controlled, crossover trial.
@nl
type
label
Metformin reduces arterial sti ...... o-controlled, crossover trial.
@en
Metformin reduces arterial sti ...... o-controlled, crossover trial.
@nl
prefLabel
Metformin reduces arterial sti ...... o-controlled, crossover trial.
@en
Metformin reduces arterial sti ...... o-controlled, crossover trial.
@nl
P2093
P921
P356
P1476
Metformin reduces arterial sti ...... o-controlled, crossover trial.
@en
P2093
D Aled Rees
Gareth Dunseath
Hemanth Bolusani
Neera Agarwal
Sam P L Rice
P304
P356
10.1210/JC.2009-1985
P407
P577
2009-12-08T00:00:00Z